Research paperEx vivo evaluation of degradation rates of metronidazole and OLSALAZINE (cas 15722-48-2) in distal ileum and in cecum: The impact of prandial state
-
Add time:09/06/2019 Source:sciencedirect.com
PurposeEvaluate ex vivo the bacterial metabolism induced degradation rates of mesalamine (negative control), metronidazole and OLSALAZINE (cas 15722-48-2) in distal ileum and in cecum.
We also recommend Trading Suppliers and Manufacturers of OLSALAZINE (cas 15722-48-2). Pls Click Website Link as below: cas 15722-48-2 suppliers
Prev:On the encapsulation of OLSALAZINE (cas 15722-48-2) by β-cyclodextrin: A DFT-based computational and spectroscopic investigations
Next:Full paperOld drug, new indication: OLSALAZINE (cas 15722-48-2) sodium reduced serum uric acid levels in mice via inhibiting xanthine oxidoreductase activity) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Determination of mesalazine, a low bioavailability OLSALAZINE (cas 15722-48-2) metabolite in human plasma by UHPLC–MS/MS: Application to a pharmacokinetic study09/24/2019
- An experimental study on ulcerative colitis as a potential target for probiotic therapy by Lactobacillus acidophilus with or without “OLSALAZINE (cas 15722-48-2)”09/10/2019
- Two three-dimensional pillared metal–OLSALAZINE (cas 15722-48-2) complexes based on infinite rod-shaped secondary building units09/09/2019
- Degradation kinetics of metronidazole and OLSALAZINE (cas 15722-48-2) by bacteria in ascending colon and in feces of healthy adults09/08/2019
- Full paperOld drug, new indication: OLSALAZINE (cas 15722-48-2) sodium reduced serum uric acid levels in mice via inhibiting xanthine oxidoreductase activity09/07/2019
- On the encapsulation of OLSALAZINE (cas 15722-48-2) by β-cyclodextrin: A DFT-based computational and spectroscopic investigations09/05/2019
- Synthesis of novel (bio) degradable linear azo polymers conjugated with OLSALAZINE (cas 15722-48-2)09/04/2019
- Enzyme and PH responsive 5-flurouracil (5-FU) loaded hydrogels based on OLSALAZINE (cas 15722-48-2) derivatives for colon-specific drug delivery09/03/2019
